Aprea Therapeutics, Inc.
APRE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13,718 | $16,532 | $19,276 | $22,850 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $226 | $395 | $559 | $726 |
| Total Curr. Assets | $13,944 | $16,927 | $19,834 | $23,576 |
| Property Plant & Equip (Net) | $65 | $71 | $76 | $82 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $41 | $0 | $40 | $40 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $271 | $312 | $271 | $282 |
| Total NC Assets | $377 | $383 | $388 | $403 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $14,321 | $17,310 | $20,222 | $23,979 |
| Liabilities | – | – | – | – |
| Payables | $641 | $1,196 | $1,282 | $1,352 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,040 | $1,972 | $2,079 | $2,009 |
| Total Curr. Liab. | $2,681 | $3,168 | $3,361 | $3,361 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $727 | $1,311 | $1,311 |
| Total NC Liab. | $0 | $727 | $1,311 | $1,311 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,681 | $3,895 | $4,672 | $4,672 |
| Equity | – | – | – | – |
| Pref Stock | $727 | $0 | $0 | $0 |
| Common Stock | $6 | $6 | $6 | $5 |
| Retained Earnings | -$331,186 | -$328,213 | -$324,975 | -$321,042 |
| AOCI | -$10,630 | -$10,628 | -$10,627 | -$10,627 |
| Other Equity | $352,722 | $352,251 | $351,146 | $350,971 |
| Total Equity | $11,640 | $13,415 | $15,550 | $19,307 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $14,321 | $17,310 | $20,222 | $23,979 |
| Net Debt | -$13,718 | -$16,532 | -$19,276 | -$22,850 |